Biote Reports Third Quarter Financial Results

Author's Avatar
Nov 08, 2022

Biote (NASDAQ: BTMD), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announced financial results for the third quarter ended September 30, 2022.